15 February 2018 - - Redwood City, California-based IT support provider Oracle Health Sciences' latest release of Oracle Argus, the company's safety and pharmacovigilance software, fully supports E2B(R3) exchange with the European Medicines Agency's (EMA's) enhanced EudraVigilance version 8, the company said.
Both Oracle Argus cloud and on-premise deployments have been tested and are fully compliant with the new EV system.
Oracle Argus, a platform that enables biopharmaceutical companies, medical device manufacturers, and contract research organisations to make faster and better safety decisions, optimise global compliance, and easily integrate with the Oracle Health Sciences Empirica platform for signal management, automates and streamlines the entire multi-vigilance lifecycle for drugs, vaccines, and devices from clinical trials through post-marketing surveillance.
The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service and Infrastructure as a Service from data centers throughout the Americas, Europe and Asia.